You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (29)

Journals (0)

1-10 of 29 results for Donanemab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Donanemab eligibility in early Alzheimer's disease: A real-world study

Retricted access

Research article

First published 2025-6

Donanemab eligibility in early Alzheimer's disease: A real-world study

Daniele Urso, Alessandro Introna, Valentina Gnoni [...]

Journal of Alzheimer’s Disease

Select article: The tale of donanemab: God is in the details

Open access

Review article

First published 2025-10

The tale of donanemab: God is in the details

Takaomi C Saido, Nobuhisa Iwata

Journal of Alzheimer’s Disease

Select article: Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective

Open access

Brief report

First published 2023-06-13

Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective

Vladimir Volloch, Sophia Rits-Volloch

Journal of Alzheimer’s Disease

Select article: Comparing clinical effect sizes of Souvenaid TM,lecanemab,and donanemab in early Alzheimer’s disease

Retricted access

Research article

First published 2026-2

Comparing clinical effect sizes of Souvenaid TM,lecanemab,and donanemab in early Alzheimer’s disease

Vincenzo Solfrizzi, Bruno P Imbimbo

Journal of Alzheimer’s Disease

Select article: Comparative efficacy,tolerability,and acceptability of aducanumab,lecanemab,and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis

Retricted access

Review article

First published 2025-11

Comparative efficacy,tolerability,and acceptability of aducanumab,lecanemab,and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis

Itsuki Terao, Wakako Kodama

Journal of Psychopharmacology

Select article: Comparative Efficacy,Tolerability,and Acceptability of Donanemab,Lecanemab,Aducanumab,Melatonin,and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis

Retricted access

Review article

First published 2024-04-02

Comparative Efficacy,Tolerability,and Acceptability of Donanemab,Lecanemab,Aducanumab,Melatonin,and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis

Itsuki Terao, Wakako Kodama

Journal of Alzheimer’s Disease

Select article: Efficacy and APOE ε4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials

Retricted access

Review article

First published 2025-9

Efficacy and APOE ε4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials

Anderson Matheus Pereira da Silva, Luciano Falcão, Filipe Virgilio [...]

Journal of Alzheimer’s Disease

Select article: Donanemab: The dawn of disease-modifying treatment for Alzheimer’s disease in Australia

Retricted access

Editorial

First published 2025-8

Donanemab: The dawn of disease-modifying treatment for Alzheimer’s disease in Australia

Samantha M Loi, Matthew JY Kang

Australasian Psychiatry

Select article: Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease

Retricted access

Research article

First published 2025-9

Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease

Heii Arai, Satoko Aiba, Reiko Arai

Journal of Alzheimer’s Disease

Select article: An Update of the Treatment Landscape for Alzheimer’s Disease: From Symptomatic Treatments to the Emergence of Amyloid-Targeting Therapies

Open access

Review article

First published 2025

An Update of the Treatment Landscape for Alzheimer’s Disease: From Symptomatic Treatments to the Emergence of Amyloid-Targeting Therapies

Amy Kovacik, Kathleen Vandergriff, Bill Jarrett [...]

Sage Open Aging

1
2
3
10 / page

Article type

Publication date

Subjects

Access